Is Good Clinical Practice Becoming Poor Clinical Care?

by Steven Le Gouill, Martin Dreyling, Maria Dolores Caballero, Marc Andre, Jeannette Doorduijn, Wojciech Jurczak, Mats Jerkeman, Paolo Ghia, Pier-Luigi Zinzani, Maria Gomez Da Silva, Meletios Dimopoulos, Marek Trneny, Richard Delarue, Jan Walewski, Christian Gisselbrecht, Armando López-Guillermo, Simon Rule
Published 2017-12-01

Biological Features and Prognostic Impact of Bone Marrow Infiltration in Patients with Diffuse Large B-cell Lymphoma

by Sara Alonso-Álvarez, Miguel Alcoceba, María García-Álvarez, Oscar Blanco, Marta Rodríguez, Mónica Baile, Juan Carlos Caballero, Julio Dávila, María Belén Vidriales, Carmen Esteban, Piedad Arias, Luis G. Díaz, Pilar Tamayo, María Dolores Caballero, Norma C. Gutiérrez, Marcos González, Alejandro Martín
Published 2020-02-01

Measures to Maintain a SARS-CoV-2 Negative Inpatient Hematological Unit in the Midst of the COVID-19 Pandemic

by Almudena Cabero-Martínez, Fermín Sánchez-Guijo, Lucía López-Corral, Estefanía Pérez, Alejandro Avendaño, Mónica Baile, Mónica Cabrero, Ana-Africa Martín, Angela Rodríguez, Balbina Pérez, Felipe Peña-Muñoz, Luz-Gema Román, Danylo Palomino, Lourdes López-Vázquez, María-Belén Vidriales, Marcos González-Diaz, María-Victoria Mateos, María-Dolores Caballero
Published 2020-08-01

Response‐adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lympho...

by Francisco‐Javier Peñalver, José‐Antonio Márquez, Soledad Durán, Pilar Giraldo, Alejandro Martín, Carlos Montalbán, Juan‐Manuel Sancho, María‐José Ramírez, María‐José Terol, Francisco‐Javier Capote, Antonio Gutiérrez, Blanca Sánchez, Andrés López, Antonio Salar, Gil Rodríguez‐Caravaca, Miguel Canales, María‐Dolores Caballero, on behalf of GELTAMO (The Spanish Lymphoma Cooperative Group)
Published 2019-11-01